[Home]   [Full version]  

Genetic defect links respiratory disease and congenital heart disease

Jun 11 ,Medicine & Health


The same genetic defect that causes a rare respiratory disease may also lead to some types of congenital heart disease, according to a study from the University of North Carolina at Chapel Hill School of Medicine.

The link between the two diseases starts with cilia, the tiny, hair-like
extensions that help the lungs clear of mucus and remove contaminants
such as dust. The researchers first noticed the connection in children
with a respiratory disease that affects cilia, primary ciliary dyskinesia (PCD). A genetic mutation that impairs cilia movement causes the disease. A few children treated for PCD at UNC-Chapel Hill also had heterotaxy - an abnormal position of the heart and lungs associated with congenital heart disease.

The research team wondered if PCD and heterotaxy were related because
other types of cilia, called nodal cilia, are known to play a role in directing and organizing organs in developing embryo. Results of the new study indicate they are connected.

The prevalence of heterotaxy and congenital heart defects was 200-fold
higher in people with PCD than in the general population (one in 50
versus one in 10,000), the study found. The research appears in the June
5, 2007, issue of the journal Circulation.

"This should spur physicians treating patients with congenital heart disease to be more vigilant about testing for and treating respiratory defects," said Dr. Michael R. Knowles, professor of pulmonary and critical care medicine and study senior author. "It is critical for
families and physicians to recognize when congenital heart disease
develops."

Children with both heterotaxy and congenital heart disease typically undergo surgery to repair heart defects, and if they have respiratory
complications after surgery, it's often assumed that the cause is their heart problems, Knowles said. But the study indicates these children's respiratory problems may also have an underlying genetic cause.

Knowles partnered with Dr. Margaret Leigh, professor of pediatrics, and
Dr. Marcus P. Kennedy, then a fellow in pulmonary and critical care medicine at UNC-Chapel Hill, to examine the connection between PCD and heterotaxy.

Out of 337 patients with PCD, 21 (6. 3 percent) had heterotaxy. The researchers performed genetic testing on 12 patients with heterotaxy and
found that seven of them had one of two genetic mutations identified as
causing PCD.

"Now when we see a patient with heterotaxy and a heart defect, then
we're going to know to look for ciliary dysfunction," said Dr. Blair V. Robinson, clinical associate professor of pediatrics at UNC-Chapel Hill and an author of the study. "In addition, the associations between ciliary function, the heart defects and the organization of organs in the chest and abdomen will hopefully lead to better understanding of how
these defects develop."


Source: University of North Carolina School of Medicine

Related stories:

Adults with aortic valve disorder do not experience reduction in survival rate
Young adults with a bicuspid aortic valve, a congenital heart abnormality, experience subsequent cardiac events but do not appear to have lower survival rates compared to the general population, according to a study in the September 17 issue of JAMA.
Stem cell regeneration repairs congenital heart defect
Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. Publication of the discovery was expedited by the editors of Stem Cells and appeared online in the "express" section of the journal's Web site at http://stemcells.alphamedpress.org/.
Aberrations in region of chromosome 1q21.1 associated with broad range of disorders in children
Researchers have discovered a submicroscopic aberration in a particular region of human chromosome 1q21.1 that appears to be associated with a variety of developmental disorders in children. The aberration can manifest itself as unexplained mild or moderate mental retardation, growth retardation, learning disabilities, seizures, autism, heart defects, other congenital abnormalities, cataracts, small head size, unusual facial features, hand deformities, or skeletal problems. Some people who have the aberration are only slightly affected or apparently unaffected, others are more seriously impaired.
70 years old and going strong with Down syndrome and no dementia
In the world of Down syndrome, 'Mr. C' is a rarity. A real person whose progress has been tracked for the past 16 years, at seventy, 'Mr. C' has well surpassed the average life expectancy of a person with Down syndrome, currently in the late fifties, but in the teens when 'Mr. C' was born. Further, 'Mr. C' does not exhibit clinical symptoms of Alzheimer's disease, which is almost a given for people with typical Down syndrome over 65 yeas of age.
More aortic chest aneurysms being treated with less-invasive stents
An estimated 60,000 Americans are walking around with time bombs in their chests called thoracic aortic aneurysms. At any time, their main chest artery could suddenly burst open, causing massive internal bleeding that is almost always fatal.
Researchers define characteristics, treatment options for XXYY syndrome
Researchers at the UC Davis M.I.N.D. Institute and The Children's Hospital in Denver have conducted the largest study to date describing the medical and psychological characteristics of a rare genetic disorder in which males have two "X" and two "Y" chromosomes, rather than the normal one of each. The study, published in the June 15, 2008, issue of the American Journal of Medical Genetics Part A, also offers treatment recommendations for men and boys with the disorder.
Combining medical knowledge to save lives
European researchers hope to gain more insight into cardiovascular disease by combining clinical, laboratory and metabolic records with genomic data.
Cardiovascular disease (CVD) is the biggest killer among chronic diseases, claiming 17 million lives globally every year. Yet doctors can only attribute 50% of cardiovascular diseases to known risk factors.
Scientists develop a mouse model of sudden infant death syndrome
Sudden Infant Death Syndrome (SIDS) is a condition that unexpectedly and unexplainably takes the lives of seemingly healthy babies aged between a month and a year. Now researchers of the European Molecular Biology Laboratory in Monterotondo, Italy, have developed a mouse model of the so-called crib or cot death, which remains the leading cause of death during the first year of life in developed countries. The model, published in this week's issue of Science, reveals that an imbalance of the neuronal signal serotonin in the brainstem is sufficient to cause sudden death in mice.

News discussion:

Medicine & Health news

[Home]   [Full version]